Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroprotective Drugs”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Large-scale testing (Phase 3)Study completedNCT01388738
What this trial is testing

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Who this might be right for
Stroke
Clinical Institute of the Brain, Russia 30
Testing effectiveness (Phase 2)Study completedNCT03161028
What this trial is testing

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
VA Office of Research and Development 115
Testing effectiveness (Phase 2)Study completedNCT00013585
What this trial is testing

Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients

Who this might be right for
Cognition DisordersHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 127
Not applicableStudy completedNCT04235673
What this trial is testing

Oral Melatonin as Neuroprotectant in Preterm Infants

Who this might be right for
MalondialdehydeMelatonin
Francesca Garofoli 60
Testing effectiveness (Phase 2)Study completedNCT02104661
What this trial is testing

Protective Role of Oxcarbazepine in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Queen Mary University of London 30
Large-scale testing (Phase 3)Study completedNCT01726075
What this trial is testing

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
BCN Peptides 450
Testing effectiveness (Phase 2)Ended earlyNCT01502761
What this trial is testing

Intra-arterial Magnesium Administration for Acute Stroke

Who this might be right for
Acute Stroke
University of Southern California 4
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00877604
What this trial is testing

Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 34
Not applicableLooking for participantsNCT06550167
What this trial is testing

Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances

Who this might be right for
Addiction;Drug(S);LSDNeuroprotective
Distribuidora Biolife SA de CV 80
Testing effectiveness (Phase 2)Study completedNCT01553916
What this trial is testing

Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain

Who this might be right for
Small Cell Lung Carcinoma
Washington University School of Medicine 19
Not applicableStudy completedNCT02107638
What this trial is testing

Effect of Osteopathic Manipulative Medicine on Parkinson Disease

Who this might be right for
Parkinson Disease
New York Institute of Technology 33
Large-scale testing (Phase 3)Ended earlyNCT00220675
What this trial is testing

Erythropoietin Spinal Cord Compression Randomized Trial

Who this might be right for
Nerve Compression Syndromes
Sunnybrook Health Sciences Centre 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT06788626
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Who this might be right for
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective Drugs+1 more
Wei Hu 390
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122559
What this trial is testing

Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Emmanuelle Waubant, MD PhD 98
Post-approval studies (Phase 4)Looking for participantsNCT06353334
What this trial is testing

Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

Who this might be right for
ButylphthalideCardiac ArrestNeuroprotective Drugs
Tang Ziren 100
Not applicableUnknownNCT01556854
What this trial is testing

Comparative Effectiveness of Neuroprotectants on Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
yongjun wang 20,000
Large-scale testing (Phase 3)Study completedNCT01188811
What this trial is testing

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Chronic Progressive
VA Office of Research and Development 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04876638
What this trial is testing

Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)

Who this might be right for
Aneurysm, RupturedVasospasm, IntracranialDelayed Cerebral Ischemia+1 more
University of Southern California 20
Next Page